Adamantane Derivative: a Novel Means of Therapy of Chronic Arterial Occlusive Disease of the Lower Extremities

Author： Kovalev I. E.   Koshkin V. M.   Shipulina N. V.   Rumyantseva E. I.  

Publisher： Springer Publishing Company

ISSN： 0091-150X

Source： Pharmaceutical Chemistry Journal, Vol.38, Iss.3, 2004-03, pp. : 117-119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytostatic gene therapy for occlusive vascular disease

By González José M   Andrés Vicente  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 4, 2006-04 ,pp. : 507-522

Informa Healthcare

Access to resources Recommend Favorite

Systemic antiatherosclerotic treatment for the peripheral arterial occlusive disease patient

By Baumgartner Iris  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 13, 2005-10 ,pp. : 2181-2192

Informa Healthcare

Access to resources Recommend Favorite

Peripheral Arterial Occlusive Disease as a Predictor of the Extent of Coronary Atherosclerosis in Patients with Coronary Artery Disease with and without Diabetes Mellitus

By Papanas N   Tziakas D   Maltezos E   Kekes A   Hatzinikolaou E   Parcharidis G   Louridas G   Hatseras D  

The Journal of International Medical Research, Vol. 32, Iss. 4, 2004-07 ,pp. : 422-428

Field House Publishing

Access to resources Recommend Favorite

Medical Management for Chronic Atherosclerotic Peripheral Arterial Disease

By >   Carman Teresa L.  

Drugs, Vol. 72, Iss. 16, 2012-11 ,pp. : 2073-2085

Adis International

Access to resources Recommend Favorite

Protective Effect of the K + Channel Opener KRN4884 on Peripheral Occlusive Arterial Disease in Rats - a comparison with levcromakalim, nilvadipine, and nifedipine

By Yoshino T.   Ohta H.   Jinno Y.   Torii Y.   Ogawa N.   Izawa T.   Okada Y.  

General Pharmacology, Vol. 31, Iss. 1, 1998-07 ,pp. : 59-62

Elsevier

Access to resources Recommend Favorite